MilliporeSigma receives the industry's first EXCiPACT certification for cell culture media manufacturing

Ibex Medical Analytics achieves notable milestones with its AI-first approach to cancer diagnostics

Albertsons Companies pharmacies now offer COVID and flu vaccines to help protect communities this respiratory virus season

OmniSYS rebrands as XiFin Pharmacy Solutions, launches Pharmacy Payor Rate Transparency Monitor, and earns the Pharmacy 500 Award

Gilead’s Livdelzi (Seladelpar) receives FDA accelerated approval for primary biliary cholangitis

ProJenX announces the formation of its Clinical Advisory Board

Citius Pharmaceuticals' LYMPHIR™ wins FDA approval for relapsed/refractory cutaneous T-cell lymphoma

NewAmsterdam Pharma announces positive topline data from the Phase 3 BROOKLYN trial of Obicetrapib in heterozygous familial hypercholesterolemia patients

Cygnus Technologies and TriLink BioTechnologies® collaborate to launch AccuRes™ Host Cell DNA Quantification Kits

Neurocrine Biosciences Launches INGREZZA® SPRINKLE (valbenazine) Capsules.

Updated flu and COVID-19 vaccinations are now available at CVS Pharmacy® and MinuteClinic

$FDA Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Relapsed or Refractory Follicular Lymphoma$

FDA Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Relapsed or Refractory Follicular Lymphoma

Featured Press Releases

NS Pharma announces a leadership change, appointing new commercial head to drive strategic growth and innovation

CalciMedica Announces Positive Topline Data from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis

27 Jun 2024

CalciMedica Inc. a clinical-stage biopharmaceutical company focused on developing novel calcium...

Eximia Research Network expands into Virginia by integrating Tidewater Clinical Research

Baird Medical’s MWA system has achieved successful Medicare reimbursement at a prominent New York practice

VahatiCor Closes Oversubscribed Series B Financing to Speed Up A-FLUX® Development for Coronary Microvascular Dysfunction

Epia Neuro Launches Intent-Driven Neural Technology to Restore Function After Stroke and Address Cognitive Decline

MinuteClinic highlights improved access and outcomes through its clinically supervised weight-loss program

By CVS Health
CVS Health
13 May 2026

Kerri McCullough Wood Named Chief Commercial Officer at Avid Bioservices

By Avid Bioservices
Avid Bioservices
12 May 2026

BIZENGRI® (Zenocutuzumab-zbco) Wins FDA Approval for NRG1 Fusion-Positive Cholangiocarcinoma, Says Partner Therapeutics

By Partner Therapeutics, Inc.
Partner Therapeutics, Inc.
12 May 2026

Miach Orthopaedics Appoints Jamal Rushdy as President & CEO

By Miach Orthopaedics, Inc.
Miach Orthopaedics, Inc.
11 May 2026

Avenacy Announces U.S. Launch of Ready-to-Use Tranexamic Acid in 0.7% Sodium Chloride Injection

By Avenacy
Avenacy
11 May 2026

New Study Suggests 5-MTHF as Effective Alternative to Folic Acid in Later Pregnancy

By Ritual
Ritual
07 May 2026

The Digital Pharma Advances Conference 2026

Most Popular

Dr. Behzad Mahdavi Has Been Appointed Executive Chairman of Biodextris to Lead Its Global Commercial Expansion

By Biodextris

Jun 04
BARDA and Tiba Biotech Collaborate to Develop Next-Gen Influenza Therapeutics

By Tiba Biotech

Jul 11
Merck’s once-daily IDVYNSO™ (doravirine/islatravir) receives FDA approval

By Merck & Co., Inc.

Apr 21

May 2026

M	T	W	T	F	S	S
				1	2	3
4	5	6	7	8	9	10
11	12	13	14	15	16	17
18	19	20	21	22	23	24
25	26	27	28	29	30	31

Search your requirement

Social media

MilliporeSigma receives the industry's first EXCiPACT certification for cell culture media manufacturing

Ibex Medical Analytics achieves notable milestones with its AI-first approach to cancer diagnostics

Albertsons Companies pharmacies now offer COVID and flu vaccines to help protect communities this respiratory virus season

OmniSYS rebrands as XiFin Pharmacy Solutions, launches Pharmacy Payor Rate Transparency Monitor, and earns the Pharmacy 500 Award

Gilead’s Livdelzi (Seladelpar) receives FDA accelerated approval for primary biliary cholangitis

ProJenX announces the formation of its Clinical Advisory Board

Citius Pharmaceuticals' LYMPHIR™ wins FDA approval for relapsed/refractory cutaneous T-cell lymphoma

NewAmsterdam Pharma announces positive topline data from the Phase 3 BROOKLYN trial of Obicetrapib in heterozygous familial hypercholesterolemia patients

Cygnus Technologies and TriLink BioTechnologies® collaborate to launch AccuRes™ Host Cell DNA Quantification Kits

Neurocrine Biosciences Launches INGREZZA® SPRINKLE (valbenazine) Capsules.

Updated flu and COVID-19 vaccinations are now available at CVS Pharmacy® and MinuteClinic

FDA Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Relapsed or Refractory Follicular Lymphoma

Featured Press Releases

NS Pharma announces a leadership change, appointing new commercial head to drive strategic growth and innovation

CalciMedica Announces Positive Topline Data from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis

Eximia Research Network expands into Virginia by integrating Tidewater Clinical Research

Baird Medical’s MWA system has achieved successful Medicare reimbursement at a prominent New York practice

VahatiCor Closes Oversubscribed Series B Financing to Speed Up A-FLUX® Development for Coronary Microvascular Dysfunction

Epia Neuro Launches Intent-Driven Neural Technology to Restore Function After Stroke and Address Cognitive Decline

MinuteClinic highlights improved access and outcomes through its clinically supervised weight-loss program

Kerri McCullough Wood Named Chief Commercial Officer at Avid Bioservices

BIZENGRI® (Zenocutuzumab-zbco) Wins FDA Approval for NRG1 Fusion-Positive Cholangiocarcinoma, Says Partner Therapeutics

Miach Orthopaedics Appoints Jamal Rushdy as President & CEO

Avenacy Announces U.S. Launch of Ready-to-Use Tranexamic Acid in 0.7% Sodium Chloride Injection

New Study Suggests 5-MTHF as Effective Alternative to Folic Acid in Later Pregnancy

Most Popular

Dr. Behzad Mahdavi Has Been Appointed Executive Chairman of Biodextris to Lead Its Global Commercial Expansion

BARDA and Tiba Biotech Collaborate to Develop Next-Gen Influenza Therapeutics

Merck’s once-daily IDVYNSO™ (doravirine/islatravir) receives FDA approval

User Area

Discover

Engage with Us

Search your requirement

Social media

Featured Press Releases

Most Popular

User Area

Discover

Engage with Us

Subscribe to Our Monthly Newsletter